Breakthrough invasive fungal infection under the use of posaconazole and voriconazole
Journal
Journal of the Formosan Medical Association
Journal Volume
115
Journal Issue
5
Pages
384-385
Date Issued
2016
Author(s)
SDGs
Other Subjects
amphotericin B deoxycholate; amphotericin B lipid complex; cyclophosphamide; cyclosporin; etanercept; fludarabine; galactomannan; methylprednisolone; mycophenolate mofetil; posaconazole; thymocyte antibody; voriconazole; antifungal agent; posaconazole; triazole derivative; voriconazole; abscess; adult; allogeneic hematopoietic stem cell transplantation; antibiotic prophylaxis; case report; chimera; Colletotrichum; Colletotrichum coccodes; computer assisted tomography; Cunninghamella; deterioration; drug substitution; drug treatment failure; drug withdrawal; engraftment; fungus growth; graft versus host reaction; hospital readmission; human; human tissue; kidney tubule acidosis; Letter; male; middle aged; minimum inhibitory concentration; multiple organ failure; neutrophil; peripheral T cell lymphoma; recurrent disease; reduced intensity conditioning; septic shock; sibling; systemic mycosis; tracheobronchial toilet; whole body radiation; complication; hematopoietic stem cell transplantation; Invasive Fungal Infections; isolation and purification; Lymphoma, T-Cell, Peripheral; multidrug resistance; Opportunistic Infections; Antifungal Agents; Colletotrichum; Drug Resistance, Multiple, Fungal; Hematopoietic Stem Cell Transplantation; Humans; Invasive Fungal Infections; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Opportunistic Infections; Triazoles; Voriconazole
Publisher
Elsevier B.V.
Type
journal article